Altamira Therapeutics Ltd.
CYTOF
$0.07
-$0.01-13.33%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -94.20% | -94.20% | 36.10% | 36.10% | 18.23% |
| Total Receivables | 75.93% | 75.93% | 295.16% | 295.16% | -86.23% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -59.57% | -59.57% | -98.11% | -98.11% | -82.03% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -65.40% | -65.40% | -5.11% |
| Total Current Assets | -52.75% | -52.75% | 5.99% | 5.99% | -72.89% |
|
|
|||||
| Total Current Assets | -52.75% | -52.75% | 5.99% | 5.99% | -72.89% |
| Net Property, Plant & Equipment | 3.14% | 3.14% | 372.58% | 372.58% | -3.62% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 6.34% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -11.64% | -11.64% | -5.37% | -5.37% | 16.39% |
|
|
|||||
| Total Accounts Payable | 44.95% | 44.95% | 6.91% | 6.91% | -76.01% |
| Total Accrued Expenses | 56.07% | 56.07% | 18.19% | 18.19% | -55.21% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.23% | 18.23% | 3.38% | 3.38% | -95.09% |
| Total Finance Division Other Current Liabilities | -- | -- | -16.05% | -16.05% | -- |
| Total Other Current Liabilities | -- | -- | -16.05% | -16.05% | -- |
| Total Current Liabilities | 88.09% | 88.09% | 10.22% | 10.22% | -79.53% |
|
|
|||||
| Total Current Liabilities | 88.09% | 88.09% | 10.22% | 10.22% | -79.53% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -34.63% | -34.63% | -- | -- | -5.44% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 150.39% | 150.39% | 66.08% | 66.08% | -86.42% |
| Total Liabilities | 74.56% | 74.56% | 42.14% | 42.14% | -80.48% |
|
|
|||||
| Common Stock & APIC | 115.09% | 115.09% | -99.96% | -99.96% | -99.97% |
| Retained Earnings | -421.19% | -421.19% | 85.80% | 85.80% | 105.67% |
| Treasury Stock & Other | 60.31% | 60.31% | 86.88% | 86.88% | 418.97% |
| Total Common Equity | -35.52% | -35.52% | -14.46% | -14.46% | 409.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -35.52% | -35.52% | -14.46% | -14.46% | 409.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -35.52% | -35.52% | -14.46% | -14.46% | 409.89% |
|
|
|||||